Mark Sanders

622 total citations
26 papers, 398 citations indexed

About

Mark Sanders is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Anesthesiology and Pain Medicine. According to data from OpenAlex, Mark Sanders has authored 26 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 7 papers in Physiology and 3 papers in Anesthesiology and Pain Medicine. Recurrent topics in Mark Sanders's work include Inhalation and Respiratory Drug Delivery (15 papers), Asthma and respiratory diseases (6 papers) and Substance Abuse Treatment and Outcomes (3 papers). Mark Sanders is often cited by papers focused on Inhalation and Respiratory Drug Delivery (15 papers), Asthma and respiratory diseases (6 papers) and Substance Abuse Treatment and Outcomes (3 papers). Mark Sanders collaborates with scholars based in United Kingdom, Jordan and United States. Mark Sanders's co-authors include William L. White, Mark W. Alberty, James Bruton, J. Friedheim, Nathir M. Obeidat, Mark Aston, Gareth Ambler, Joanna Kelly, Caroline Murphy and Mick Serpell and has published in prestigious journals such as Annals of Internal Medicine, Journal of Allergy and Clinical Immunology and BMC Health Services Research.

In The Last Decade

Mark Sanders

25 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Sanders United Kingdom 11 222 137 44 36 35 26 398
Helen E. Wood United Kingdom 13 124 0.6× 99 0.7× 15 0.3× 14 0.4× 17 0.5× 37 422
E Berg Sweden 11 463 2.1× 203 1.5× 42 1.0× 2 0.1× 3 0.1× 19 522
Orçin Telli Atalay Türkiye 8 217 1.0× 51 0.4× 27 0.6× 40 1.1× 18 0.5× 29 347
David Short United Kingdom 12 64 0.3× 81 0.6× 26 0.6× 16 0.4× 13 0.4× 27 322
Syed Mohammad Tariq Pakistan 7 113 0.5× 242 1.8× 11 0.3× 2 0.1× 7 0.2× 15 412
Alasdair Taylor United Kingdom 11 50 0.2× 65 0.5× 66 1.5× 9 0.3× 8 0.2× 22 349
Sung Eun Kim South Korea 13 34 0.2× 39 0.3× 9 0.2× 12 0.3× 9 0.3× 29 475
R. McCahon United Kingdom 14 80 0.4× 39 0.3× 152 3.5× 79 2.2× 14 0.4× 31 529
Karen Steckner United States 7 44 0.2× 133 1.0× 67 1.5× 56 1.6× 7 0.2× 11 316
Mert Özen Türkiye 9 26 0.1× 33 0.2× 14 0.3× 55 1.5× 11 0.3× 45 451

Countries citing papers authored by Mark Sanders

Since Specialization
Citations

This map shows the geographic impact of Mark Sanders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Sanders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Sanders more than expected).

Fields of papers citing papers by Mark Sanders

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Sanders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Sanders. The network helps show where Mark Sanders may publish in the future.

Co-authorship network of co-authors of Mark Sanders

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Sanders. A scholar is included among the top collaborators of Mark Sanders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Sanders. Mark Sanders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sanders, Mark, et al.. (2022). Relative Lung and Systemic Bioavailability Along with Oropharyngeal Deposition of Salbutamol Post-Inhalation: A Pharmacokinetic Evaluation of Novel Inhaler Technique Training Gadgets. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 35(5). 278–285. 1 indexed citations
2.
Sanders, Mark, et al.. (2021). The effect of Clip‐tone® and its smartphone application on optimisation of metered‐dose inhalers inhalation technique. International Journal of Clinical Practice. 75(6). e14088–e14088. 5 indexed citations
3.
Oriquat, Ghaleb A., et al.. (2020). Comparative pharmacokinetics of salbutamol inhaled from a pressurized metered dose inhaler either alone or connected to a newly enhanced spacer design. European Journal of Pharmaceutical Sciences. 147. 105304–105304. 6 indexed citations
4.
Obeidat, Nathir M., et al.. (2020). ATTACHED, DETACHED and WITHOUT inhaler technique coaching tools to optimize pMDI use competence, asthma control and quality-of-life in asthmatic adults. Journal of Thoracic Disease. 12(5). 2415–2425. 9 indexed citations
6.
Sanders, Mark, et al.. (2020). Understanding flow rate influence on clip-tone guided inhaler delivery. Monash University Research Portal (Monash University). 1 indexed citations
7.
Sanders, Mark, et al.. (2018). Comparison of aerosol delivery from two inhaler technique-guidance devices.. PA4430–PA4430. 1 indexed citations
8.
Deane, Katherine, Richard Gray, Clare Darrah, et al.. (2018). Patient-directed self-management of pain (PaDSMaP) compared to treatment as usual following total knee replacement; a randomised controlled trial. BMC Health Services Research. 18(1). 346–346. 5 indexed citations
9.
Gallagher, Cathal T., et al.. (2017). Dispersing the Mists: An Experimental History of Medicine Study into the Quality of Volatile Inhalations. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 30(3). 157–163.
10.
11.
Göebel, Andreas, Jatinder Bisla, Bernhard Frank, et al.. (2017). Low-Dose Intravenous Immunoglobulin Treatment for Long-Standing Complex Regional Pain Syndrome. Annals of Internal Medicine. 167(7). 476–483. 37 indexed citations
12.
Sanders, Mark. (2017). Guiding Inspiratory Flow: Development of the In-Check DIAL G16, a Tool for Improving Inhaler Technique. Pulmonary Medicine. 2017. 1–7. 61 indexed citations
13.
Sanders, Mark, et al.. (2015). New Formulation of Sustained Release Naloxone Can Reverse Opioid Induced Constipation Without Compromising the Desired Opioid Effects. Pain Medicine. 16(8). 1540–1550. 15 indexed citations
14.
Welch, Michael J., et al.. (2015). Training tool versus instruction leaflet for pMDI use - A controlled group comparative study. PA1236–PA1236. 2 indexed citations
15.
Göebel, Andreas, Nicholas Shenker, Candy McCabe, et al.. (2014). Low-dose intravenous immunoglobulin treatment for complex regional pain syndrome (LIPS): study protocol for a randomized controlled trial. Trials. 15(1). 404–404. 15 indexed citations
16.
Sanders, Mark. (2011). Strategies for Engaging Difficult-to-Reach, Multiproblem Clients with Substance Use Disorders. Alcoholism Treatment Quarterly. 29(1). 91–98. 4 indexed citations
17.
Rochester, Mark, et al.. (2011). Self Management Activation Randomised Trial for Prostatitis (SMART-P): study protocol for a randomised controlled trial. Trials. 12(1). 210–210. 3 indexed citations
18.
Sanders, Mark. (2007). Inhalation therapy: an historical review. Primary Care Respiratory Journal. 16(2). 71–81. 122 indexed citations
19.
Aston, Mark, et al.. (2007). A New Treatment for Wellbore Strengthening in Shale. Proceedings of SPE Annual Technical Conference and Exhibition. 27 indexed citations
20.
Hughes, Trevor, et al.. (1991). Chemical Monitoring of Mud Products on Drilled Cuttings. SPE Health, Safety and Environment in Oil and Gas Exploration and Production Conference. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026